Mahsan Nourani is a Research Assistant Professor at Northeastern University, specializing in intersections of human-computer interaction, artificial intelligence, and healthcare informatics. Their research focuses on explainable AI systems, user behavior in AI partnerships, and design of interactive machine learning tools. Current work explores cognitive biases in human-AI collaboration, predictive analytics in healthcare, and activity recognition in videos. Key research areas include user profiling in AI applications, trust dynamics in intelligent systems, and visual debugging tools for machine learning models. Notable projects include the HEART initiative for real-time healthcare analytics and development of the DETOXER explanation framework for temporal classification systems. Recent publications investigate nudge techniques for behavioral change (Romadoro project), anchoring bias effects in AI system trust, and evaluation of view rotation techniques in virtual reality navigation. Their work consistently bridges technical AI advancements with human-centered design principles. No academic awards are listed in the provided materials. Current affiliations include Northeastern University's research groups in AI ethics, human-computer interaction, and healthcare technology innovation.
Associate Professor Mathias Baumert is affiliated with the University of Adelaide, where he holds a position in the School of Electrical and Mechanical Engineering under the Faculty of Sciences, Engineering and Technology. He leads the Health Technology research theme in the School of Electrical Electronic Engineering and specializes in biomedical signal processing, focusing on dynamic electrocardiography and sleep-related phenomena. His work integrates clinical applications and technological advancements to address challenges in cardiology and sleep disorders. His research interests include the physiological underpinnings of ventricular repolarization variability and its clinical implications, particularly in post-myocardial infarction patients and those with sleep-disordered breathing. He also develops brain-computer interface (BCI) systems for stroke rehabilitation, leveraging real-time EEG analysis and motor function recovery techniques. Collaborations with clinical partners such as the Women’s and Children’s Hospital, Adelaide Institute of Sleep Health, and the Victor Chang Cardiac Research Institute highlight his translational research focus. His recent articles emphasize signal processing applications for risk stratification in cardiovascular disease, sleep apnea, and diabetes. Key themes include nocturnal hypoxemic burden prediction, REM sleep dynamics, and the development of novel diagnostic markers using ECG and EEG data. His work often bridges engineering and medicine, aiming to translate findings into clinical tools like adaptive servo-ventilation treatment optimization and personalized BCI systems. No scientific awards or fellowships are explicitly listed in the provided texts. He is eligible to supervise Masters and PhD students but current advisee names are not available. His research projects are supported by grants such as ARC DP110102049 (as noted in some articles). He teaches courses including Biomedical Instrumentation and Introduction to Medical Technology . His facilities include ECG equipment, polysomnogram repositories, and a BCI workstation with 64-channel EEG capabilities. He collaborates on lab-based and clinical partner studies to advance cardiac sensing algorithms and sleep-related diagnostic technologies.
Michele De Bonis is an Associate Professor of Cardiac Surgery at the Medical School of Vita-Salute San Raffaele University in Milan, Italy. He serves as Chief of Cardiac Surgery Innovation and Research at San Raffaele University Hospital, Director of the Training School in Cardiac Surgery, and Head of the Heart Failure Surgery Unit and Mechanical Circulatory Support Programme. He holds visiting professorships at Plymouth NHS Trust (UK) and Cape Town University (South Africa). His clinical expertise includes mitral/tricuspid valve repair, mechanical circulatory support (LVAD/ECMO), and transcatheter interventions. He has pioneered the Star-Tric System for tricuspid regurgitation and is a certified proctor for HeartMate devices. Education: MD cum laude from Rome’s Catholic University (1993), postgraduate training in Belgium/UK, and a fellowship in mechanical support at Berlin’s German Heart Institute. He is a Fellow of the American Heart Association (FAHA) and European Society of Cardiology (FESC). Research focuses on valvular heart disease and mechanical circulatory support, with over 466 publications (H-index>20, 3000+ citations). He co-authored European guidelines on valvular disease and infective endocarditis. Teaching roles include courses at the European School for Cardiothoracic Surgery and mentorship of over 20 theses. He leads funded projects like the €980k PNRR-MAD-2022 lung frailty study and the €500k ECMO outcomes project. Awards include the 2005 Ciociaria Medicine Prize and 1995 Petrone Award. He chairs EACTS task forces and serves on international committees for the American Heart Association and European Society of Cardiology.
Lionel Hebbard is a Professor in the Department of Molecular and Cellular Biology at James Cook University's College of Medicine and Dentistry. His research spans hepatocellular carcinoma mechanisms, metabolic liver disease, and cancer therapeutics with significant contributions to adiponectin biology and sarcopenia assessment in cardiac surgery. James Cook University (Current) Department of Molecular and Cellular Biology College of Medicine and Dentistry Senior Researcher in Liver Cancer Biology His research focuses on hepatocellular carcinoma pathogenesis , particularly adiponectin signaling pathways and liver cancer stem cells. He investigates non-alcoholic fatty liver disease progression to cancer, metabolic drivers of tumorigenesis, and therapeutic targeting using aptamer-based delivery systems. Recent work explores sarcopenia quantification via CT imaging for cardiac surgery risk prediction, demonstrating clinical translation of his molecular findings. His lab employs advanced techniques including CRISPR screening (TARGET-SL platform), in vitro cancer models, and murine tumor systems. Analysis of his 15 most recent publications reveals strong emphasis on translational liver cancer research (60%), cardiac surgery complications (20%), and emerging biotechnologies (20%). Key trends include adiponectin's dual roles in fibrosis and tumorigenesis, sarcopenia as a surgical biomarker, and aptamer-based targeting of cancer stem cells. His work consistently bridges molecular mechanisms with clinical applications, particularly in hepatocellular carcinoma diagnostics and treatment. He mentors multiple doctoral students and early-career researchers including Rhys Gillman and Miriam Wankell. His research is supported by continuous funding from Australian NHMRC and international collaborations with George Jacob (Westmead Institute), Qiao Liang (Bentham Books), and Ranscht Barbara (T-cadherin studies). He leads the Hepatic Cancer Biology laboratory focusing on: Liver cancer stem cell characterization Adiponectin receptor signaling in HCC Metabolic drivers of tumor progression Novel drug delivery systems for liver cancer Translational sarcopenia assessment tools
Johannes R. Kratz, MD, is an Associate Professor in the Department of Surgery at the University of California, San Francisco (UCSF), School of Medicine. He holds the Van Auken Endowed Chair in Thoracic Oncology and serves as Interim Chief of the Division of Thoracic Surgery. Kratz is also the Program Director of the Thoracic Surgery Residency Program, Director of Minimally Invasive and Robotic Thoracic Surgery, and Medical Director of Robotic Surgery at UCSF Health, highlighting his dual leadership in both academic and clinical domains. He earned his M.D. magna cum laude from Harvard Medical School, a Master of Arts in Philosophy from Stanford University, and completed his clinical training including a residency in General Surgery at Massachusetts General Hospital and a fellowship in Cardiothoracic Surgery at UCSF. His academic credentials are further strengthened by additional training in Diversity, Equity, and Inclusion from UCSF. Kratz’s research is centered on improving outcomes for patients with early-stage thoracic malignancies. His work focuses on developing and validating molecular prognostic assays, particularly a 14-gene signature for lung cancer, understanding tumor immunology, and advancing precision medicine through multi-omics and organoid models. He leads the Kratz Lab, which investigates the genetic and immunological drivers of lung, esophageal, and thymic cancers to discover novel therapeutic targets. His most recent publications, spanning 2023–2025, reveal a strong emphasis on neoadjuvant targeted therapies (especially osimertinib), immune microenvironment profiling using spatial and single-cell techniques, molecular risk stratification, and surgical outcomes research. His work bridges clinical trials, translational science, and surgical innovation, with a growing interest in the impact of the pandemic on surgical care and biomarker development for precision oncology. Scientific Awards and Honors: Van Auken Endowed Chair in Thoracic Oncology (2018) Michael DeBakey Research Scholarship, American Association for Thoracic Surgery (2019) Hellman Family Clinical-Translational Research Development Award (2019) UCSF Health Exceptional Physician Award (2017) Haile T. Debas Academy of Medical Educators Excellence in Teaching Award (2019, 2023) Cardiothoracic Surgery Faculty Teaching Award (2021) Soma Weiss Scholar, Harvard Medical School (2005) Howard Hughes Research Training Fellowship (2004) Kratz has been a Principal Investigator on multiple grants from the American Association of Thoracic Surgery, Bakar ImmunoX Foundation, Helen Diller Family Comprehensive Cancer Center, and UCSF. He actively mentors surgical trainees and contributes to medical education, reflected in his residency program leadership and teaching awards. He is also involved in clinical trials related to minimally invasive surgery and perioperative care. His lab, launched in 2018, is a hub for innovative research in early-stage lung cancer therapeutics.
Dr. David Strosberg is an Assistant Professor of Surgery in the Division of Vascular and Endovascular Surgery at Yale School of Medicine and practices at Yale New Haven Hospital. He specializes in open, endovascular, and hybrid treatments for complex vascular conditions, including aortic disease, carotid stenosis, critical limb ischemia, and thoracic outlet syndrome, with a focus on patients with connective tissue disorders. Assistant Professor of Surgery, Yale School of Medicine Division of Vascular and Endovascular Surgery Yale New Haven Hospital VA Connecticut Healthcare, West Haven Education: MD, Upstate Medical University - State University of New York MS in Medical Science, Ohio State University Residency: The Ohio State University Wexner Medical Center (Administrative Chief Resident) Vascular Surgical Fellowship: Johns Hopkins Hospital Dr. Strosberg's research interests center on medical education, particularly simulation and curriculum development for medical students and residents. He has been recognized with multiple teaching awards at institutional, regional, and national levels, reflecting his commitment to surgical training excellence. His recent publications span vascular surgery and biomedical engineering, with a focus on hemodynamic modeling, revascularization outcomes, and innovations in dialysis access. These works reflect a strong interdisciplinary approach involving computational modeling, clinical outcomes analysis, and surgical innovation. Scientific Awards and Honors: Finalist, Distinguished Teaching Society (2020) Resident and Fellows Case Competition Winner, Johns Hopkins (2019) Resident of the Year Award, The Ohio State University (2018) Resident Teacher Award, The Ohio State University (2018) Robyn D. Howson Housestaff Humanism Award, The Ohio State University (2018) Dr. Strosberg is actively involved in clinical teaching and has received grant support for surgical education initiatives, including the Surgical Education Solutions grant. He collaborates extensively with vascular researchers at Yale, including Dr. Alan Dardik and Dr. Cassius Iyad Ochoa Chaar. He is part of the Thoracic Outlet Syndrome Program and contributes to advancing vascular care through both clinical innovation and educational leadership.
Melanie Tory is a Professor at Northeastern University's Khoury College of Computer Sciences, serving as Professor of the Practice and Director of Data Visualization. Her research focuses on data visualization and human-centered computing, with interdisciplinary applications in healthcare, energy systems, and natural language processing. Her recent work explores the intersection of machine learning and visualization in domains like cardiothoracic care and wind farm optimization. She also investigates conversational interfaces for data visualization, focusing on intent recognition and pragmatic language use in analytical workflows. Key projects include the HEART initiative for real-time medical analytics and schema design for dynamic visualizations. Melanie advises PhD students Carey Barry, Shani Spivak, and Timothy Yim, and contributes to visualization education through research faculty roles. She actively publishes in venues like IEEE PacificVis, addressing challenges in visual utility evaluation, vague command modifiers, and collaborative analysis.
Dr. Stephen G. Swisher serves as Division Head of Surgery and Professor in the Department of Thoracic and Cardiovascular Surgery at The University of Texas MD Anderson Cancer Center. He also holds the Charles A. LeMaistre Distinguished Chair in Thoracic Oncology and co-leads the lung cancer initiative within MD Anderson's Moon Shots Program. His primary research interests include: Thoracic Surgical Oncology Lung Cancer Esophageal Cancer Gene Therapy Clinical Trials Cardiothoracic Surgical Techniques With over 350 peer-reviewed publications, Dr. Swisher's research has pioneered gene therapy clinical trials in lung and esophageal cancer. His work has been primarily supported by the Department of Defense and the National Institutes of Health/National Cancer Institute, focusing on translating research findings into improved surgical outcomes for cancer patients. His professional honors include: Charles A. LeMaistre Distinguished Chair in Thoracic Oncology (2014) Robert F. Fly Professorship of Surgical Oncology Consistent recognition among top doctors and surgeons in Texas and nationally Dr. Swisher holds significant leadership positions including: Member, Lung Cancer Working Group of the Southwest Oncology Group ALCHEMIST Core Committee member, NCI's Cancer Therapy Evaluation Program Member, NCI Thoracic Malignancies Steering Committee His career at MD Anderson spans nearly three decades, beginning as an assistant professor in 1996, achieving associate professor in 2001, early promotion to full professor in 2005, department chair in 2007, and Division Head of Surgery in 2014.
Anthony J. Carlese, D.O., is an Associate Professor in the Department of Medicine (Critical Care) and Department of Cardiothoracic & Vascular Surgery at Albert Einstein College of Medicine. He serves as Medical Director of the Cardiothoracic Intensive Care Unit at Montefiore Medical Center's Moses campus, Medical Director of the Montefiore/Einstein adult Extracorporeal Life Support Program (ECMO), Medical Director of Respiratory Therapy (Moses campus), and Medical Director of the Adult Critical Care Physician Assistant Program. Dr. Carlese's educational background includes: Bachelor of Science in Chemistry from Villanova University (1987) Doctor of Osteopathy from New York College of Osteopathic Medicine (1991) Internship at Brookdale Hospital Medical Center (1992) Categorical Internal Medicine Residency at Beth Israel Medical Center (1995) Pulmonary Fellowship at Albany Medical Center (1997) Critical Care Medicine Fellowship at University of Pittsburgh Medical Center (1998) His research emphasizes clinical outcomes in cardiac surgery and ECMO programs and pioneering virtual reality applications for postoperative pain management and delirium prevention. Clinical expertise spans complex hemodynamic monitoring, care for patients after coronary bypass/valvular surgery, and management of next-generation mechanical circulatory support devices. Professional recognition includes: Fellow of the American College of Chest Physicians Dr. Carlese actively shapes medical education as Co-Director of Albert Einstein College of Medicine's Critical Care Medicine elective (K608) and through extensive ECMO-focused lectures across NYC. His leadership encompasses physician assistant program development and respiratory therapy oversight. He directs multidisciplinary teams in the Cardiothoracic ICU and ECMO program, integrating advanced mechanical assist devices and hemodynamic technologies to optimize critical care outcomes for complex cardiac and respiratory failure cases.
Andrew V. Scott, MD, serves as a Clinical Assistant Professor in the Department of Anesthesiology at the University of Utah, providing clinical care at University of Utah Hospital in Salt Lake City. Board-certified by the American Board of Anesthesiology and National Board of Medical Examiners, he specializes in cardiothoracic and critical care anesthesiology with a focus on blood management. His educational trajectory includes: Undergraduate: B.S. in Biochemistry from Loyola University New Orleans Medical Degree: M.D. from Johns Hopkins University School of Medicine Internship: Internal Medicine at Mercy Medical Center, University of Maryland School of Medicine Residency: Anesthesiology at Johns Hopkins Hospital Fellowships: Critical Care Anesthesiology at Johns Hopkins Hospital Cardiothoracic Anesthesiology at University of Colorado School of Medicine Transfusion and Bloodless Medicine at Johns Hopkins University School of Medicine Dr. Scott's research centers on transfusion medicine and bloodless surgical techniques , investigating blood storage effects, autologous salvage efficacy, and outcomes in transfusion-averse patients. His work bridges perioperative physiology with practical clinical applications in high-risk surgical settings, particularly within cardiothoracic and oncologic procedures. Analysis of his 12 publications (2015-2022) reveals consistent focus on blood conservation strategies and transfusion optimization . Key themes include blood storage duration impacts, perioperative temperature management, and bloodless care protocols, with strong emphasis on clinical outcomes and cost-effectiveness in complex surgical populations. No scientific awards were documented in the source material. While no student mentoring or grant activities were specified, his collaborative publications with institutions like Johns Hopkins and University of Colorado indicate active research partnerships. His work demonstrates translational focus from laboratory investigations to clinical implementation. Though specific laboratory affiliations weren't mentioned, his publications suggest involvement in perioperative blood management initiatives and transfusion research consortia at major academic medical centers.
Kai Kuck, PhD, ME, serves as Director of Bioengineering in the Department of Anesthesiology at the University of Utah School of Medicine since 2014. With expertise spanning multiple engineering disciplines and clinical applications, he bridges the gap between medical technology development and clinical practice in anesthesia and critical care settings. His educational background includes doctoral training at the University of Utah, an ME from Hamburg University of Applied Sciences, and executive education from Babson College. This diverse academic foundation supports his interdisciplinary approach to medical device innovation. Dr. Kuck's research focuses on three primary areas: cardiorespiratory monitoring systems, intelligent decision support tools for clinicians, and advanced ventilation technologies. His work emphasizes practical solutions that address real-world clinical challenges, particularly in the operating room and critical care environments. He has pioneered non-invasive monitoring techniques, including urine oxygen monitoring for acute kidney injury detection and novel approaches to anesthetic gas concentration sensing. Analysis of his recent publications reveals a strong emphasis on solving critical clinical problems through engineering innovation. His work spans from fundamental research on physiological monitoring to practical device development, with particular focus on kidney injury prediction, propofol dosing algorithms, and ventilator technology - especially highlighted during the COVID-19 pandemic with the Utah-Stanford Ventilator project. Dr. Kuck has co-authored numerous patents related to anesthesia monitoring and delivery systems, demonstrating his commitment to translating research into practical clinical tools. His collaborations span engineering, clinical anesthesia, and critical care medicine, reflecting the interdisciplinary nature of modern medical technology development. His leadership in developing the Utah-Stanford Ventilator (Vent4US) during the pandemic exemplifies his ability to rapidly mobilize engineering resources to address urgent clinical needs. This project, along with his work on urine oxygen monitoring and propofol dosing algorithms, demonstrates his focus on technologies that improve patient outcomes through better physiological monitoring and treatment delivery.
Joshua Glazer, MD, is an Associate Professor of Emergency Medicine, Internal Medicine, and Anesthesiology at the University of Wisconsin–Madison, with a focus on clinical care in the Emergency Department and inpatient Intensive Care Units (ICUs). As Division Chief of Emergency Critical Care and chair of the UW Health Critical Care Committee and Organ & Tissue Donation Advisory Committee, he leads multidisciplinary initiatives to enhance critical care delivery and neurologically intact survival post-cardiac arrest. Undergraduate: University of Wisconsin–Madison Medical School: University of Wisconsin School of Medicine and Public Health Residency: University of Michigan (Chief Resident) Fellowship: University of Michigan (Critical Care, Health Care Administration) Dr. Glazer’s research centers on real-time risk stratification of critically ill patients and leveraging EHR data for early detection of life-threatening illnesses. His operational work includes founding the UW extracorporeal cardiopulmonary resuscitation (ECPR) program, integrating EMS, cardiothoracic surgery, emergency medicine, and critical care teams. His recent publications emphasize ECPR implementation, geospatial mapping for prehospital care, predictive modeling for resuscitation strategies, health equity in critical interventions, and EHR-driven disease identification. These span disciplines including Emergency Medicine, Critical Care, Public Health, and Medical Informatics, with subfields like resuscitation science, clinical workflow optimization, and multidisciplinary care protocols. BerbeeWalsh Faculty Award for Excellence in Scholarship (2021-22) UW Health Rising Star Leadership Award (2020) BerbeeWalsh Ripple Award for Leadership & Service (2019-20) BerbeeWalsh Faculty Award for Excellence in Teaching (2017-18) Dr. Glazer spearheads UW Health’s ECPR program, a multidisciplinary effort involving EMS, cardiothoracic surgery, and critical care teams. He also contributes to quality improvement in organ donation and resuscitation science.
Ali Y. Mansour, M.D., is an Assistant Professor at Montefiore Einstein with dual appointments in the Department of Cardiothoracic & Vascular Surgery and the Department of Medicine (Pulmonary Medicine). He serves as the Medical Director of Advanced Pulmonary Failure and Lung Transplantation. Board certified in echocardiography and vascular medicine, he is accredited as an interventional pulmonologist. Education and Training: Bachelor of Chemistry, American University of Beirut (2000) Doctor of Medicine, American University of Beirut (2004) Internship, American University of Beirut Medical College (2004) Internal Medicine Residency, Kansas University Medical School (2008) Pulmonary/Critical Care Fellowship, Baylor College of Medicine (2011) Sleep Fellowship, University Hospital Case Western Medical Center (2012) Clinical and research expertise encompasses: Clinical Focus : Interventional pulmonary medicine, lung transplantation, interstitial lung disease, vascular medicine, and sleep medicine. Research Focus : ECMO support for critical lung disease, lung cancer staging innovations, advanced airway procedures, and novel SARS-CoV-2 therapeutic trials. Professional recognition includes: Fellowship in the American College of Chest Physicians
Olasunkanmi Kehinde is an Assistant Professor in the Department of Health and Human Studies at Elizabeth City State University. Their research spans medical imaging applications in cardiology, pediatric health outcomes, and educational assessment methodologies. They hold an office in the STEM Complex Building, Room 326. Research focuses include cardiac MRI viability assessment, preterm infant mortality risk analysis, and innovative teaching strategies in STEM education. Their work integrates quantitative methods like item response theory and multilevel modeling with practical applications in healthcare and education systems. Recent publications (2021-2025) emphasize methodological advancements in educational measurement, cognitive assessment frameworks, and healthcare outcome analysis. No formal awards or grants are explicitly noted in the provided materials.
Dr. Christina E. Saikus is a Cardiothoracic, Cardiovascular, and Transplant Surgeon at Mayo Clinic in Jacksonville, Florida, with dual MD/PhD credentials in Biomedical Engineering. Her clinical practice focuses on heart and lung transplantation, mechanical circulatory support, and complex cardiac surgery. Dr. Saikus's educational journey includes: MD/PhD in Biomedical Engineering from Emory University and Georgia Institute of Technology Thoracic Surgery Residency at Emory University Fellowship in Advanced Cardiac and Thoracic Transplantation at Duke University Undergraduate degree in Chemical Engineering from Stanford University Her research interests center on cardiovascular imaging, particularly MRI-guided interventions, mechanical circulatory support, and transplantation medicine. Dr. Saikus has made significant contributions to developing real-time MRI techniques for cardiovascular procedures, focusing on device visibility, safety enhancements, and workflow optimization. Her recent work has expanded into ECMO management protocols, cardiogenic shock classification systems, and innovative approaches to mechanical support in high-risk patients. Dr. Saikus has received numerous awards including the Carlson/Mouly Award for Outstanding Clinical Associate, multiple awards from the International Society for Magnetic Resonance in Medicine, and the Women in Thoracic Surgery Scholarship Award. Her research has been consistently funded through prestigious awards including the NIH Intramural Research Training Award during her PhD studies. As a physician-scientist, Dr. Saikus bridges engineering principles with clinical applications, developing novel techniques for image-guided cardiovascular interventions while maintaining an active surgical practice in transplantation and mechanical support.
